Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?

por Govaert, Klaas M., van Kessel, Charlotte S., Lolkema, Martijn, Ruers, Theo J. M., Borel Rinkes, Inne H. M.
Publicado 2012

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia

por See, Fiona, Seki, Tetsunori, Psaltis, Peter J, Sondermeijer, Hugo P, Gronthos, Stan, Zannettino, Andrew CW, Govaert, Klaas M, Schuster, Michael D, Kurlansky, Paul A, Kelly, Darren J, Krum, Henry, Itescu, Silviu
Publicado 2011

Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability

por Jongen, Jennifer M. J., van der Waals, Lizet M., Trumpi, Kari, Laoukili, Jamila, Peters, Niek A., Schenning-van Schelven, Susanne J., Govaert, Klaas M., Borel Rinkes, Inne H. M., Kranenburg, Onno
Publicado 2017

Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19(+)- liver cells deficient for p53 and Rb

por Matondo, Ramadhan B, Toussaint, Mathilda JM, Govaert, Klaas M, van Vuuren, Luciel D, Nantasanti, Sathidpak, Nijkamp, Maarten W, Pandit, Shusil K, Tooten, Peter CJ, Koster, Mirjam H, Holleman, Kaylee, Schot, Arend, Gu, Guoqiang, Spee, Bart, Roskams, Tania, Rinkes, Inne Borel, Schotanus, Baukje, Kranenburg, Onno, de Bruin, Alain
Publicado 2016